Anti-Interleukin-1 Beta/Tumor Necrosis Factor-Alpha IgY Antibodies Reduce Pathological Allergic Responses in Guinea Pigs with Allergic Rhinitis

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2016 Apr 6

PMID 27046957

Citations 12

Authors

Hu Wei-Xu

Zhou Wen-Yun

Zhu Xi-Ling

Wen Zhu

Wu Li-Hua

Wu Xiao-Mu

Wei Hui-Ping

Wang Wen-Ding

He Dan

Xiang Qin

Hu Guo-Zhu

Affiliations

Soon will be listed here.

Abstract

This study aims to determine whether the combined blockade of IL-1β and TNF-α can alleviate the pathological allergic inflammatory reaction in the nasal mucosa and lung tissues in allergic rhinitis (AR) guinea pigs. Healthy guinea pigs treated with saline were used as the healthy controls. The AR guinea pigs were randomly divided into (1) the AR model group treated with intranasal saline; (2) the 0.1% nonspecific IgY treatment group; (3) the 0.1% anti-TNF-α IgY treatment group; (4) the 0.1% anti-IL-1β IgY treatment group; (5) the 0.1% combined anti-IL-1β and TNF-α IgY treatment group; and (6) the fluticasone propionate treatment group. The inflammatory cells were evaluated using Wright's staining. Histopathology was examined using hematoxylin-eosin staining. The results showed that the number of eosinophils was significantly decreased in the peripheral blood, nasal lavage fluid, and bronchoalveolar lavage fluid (P < 0.05), and eosinophil, neutrophil, and lymphocyte infiltration and edema were significantly reduced or absent in the nasal mucosa and lung tissues (P < 0.05) in the combined 0.1% anti-IL-1β- and TNF-α IgY-treated guinea pigs. The data suggest that topical blockade of IL-1β and TNF-α could reduce pathological allergic inflammation in the nasal mucosa and lung tissues in AR guinea pigs.

Citing Articles

IL-1β-induced epithelial cell and fibroblast transdifferentiation promotes neutrophil recruitment in chronic rhinosinusitis with nasal polyps.

Xie X, Wang P, Jin M, Wang Y, Qi L, Wu C Nat Commun. 2024; 15(1):9101.

PMID: 39438439 PMC: 11496833. DOI: 10.1038/s41467-024-53307-0.

Monoclonal IgY antibodies: advancements and limitations for immunodiagnosis and immunotherapy applications.

Tabll A, Shahein Y, Omran M, Hussein N, El-Shershaby A, Petrovic A Ther Adv Vaccines Immunother. 2024; 12:25151355241264520.

PMID: 39071998 PMC: 11273732. DOI: 10.1177/25151355241264520.

Bone marrow mesenchymal stem cells attenuate LPS-induced acute lung injury in mice by promoting RvE1/ProD1 and modulating Treg/Th17 balance.

Qian H, Zou G, Li C, He Q, Liu J Turk J Biol. 2023; 46(2):173-185.

PMID: 37533518 PMC: 10393107. DOI: 10.3906/biy-2107-83.

The IL-33-induced p38-/JNK1/2-TNFα axis is antagonized by activation of β-adrenergic-receptors in dendritic cells.

Helbig C, Weber F, Andreas N, Herdegen T, Gaestel M, Kamradt T Sci Rep. 2020; 10(1):8152.

PMID: 32424229 PMC: 7235212. DOI: 10.1038/s41598-020-65072-3.

Lour. Methanol Extract Exhibits Anti-Inflammatory Activity by Targeting Syk, Src, and IRAK1 Kinase Activity.

Ahuja A, Jeong D, Kim M, Cho J Evid Based Complement Alternat Med. 2020; 2019:6879346.

PMID: 31929819 PMC: 6942823. DOI: 10.1155/2019/6879346.

References

Magnusson B, Kligman A . The identification of contact allergens by animal assay. The guinea pig maximization test. J Invest Dermatol. 1969; 52(3):268-76. DOI: 10.1038/jid.1969.42. View

Brown J, Behndig A, Sekerel B, Pourazar J, Blomberg A, Kelly F . Lower airways inflammation in allergic rhinitics: a comparison with asthmatics and normal controls. Clin Exp Allergy. 2007; 37(5):688-95. DOI: 10.1111/j.1365-2222.2007.02695.x. View

Oka A, Matsunaga K, Kamei T, Sakamoto Y, Hirano T, Hayata A . Ongoing allergic rhinitis impairs asthma control by enhancing the lower airway inflammation. J Allergy Clin Immunol Pract. 2014; 2(2):172-8. DOI: 10.1016/j.jaip.2013.09.018. View

Camara J, Jarai G . Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. Fibrogenesis Tissue Repair. 2010; 3(1):2. PMC: 2821296. DOI: 10.1186/1755-1536-3-2. View

Nilsson E, Kollberg H, Johannesson M, Wejaker P, Carlander D, Larsson A . More than 10 years' continuous oral treatment with specific immunoglobulin Y for the prevention of Pseudomonas aeruginosa infections: a case report. J Med Food. 2007; 10(2):375-8. DOI: 10.1089/jmf.2006.214. View

Nam S, Kim M, Seo Y, Choi Y, Jang J, Kang I . The (2'S,7'S)-O-(2-methylbutanoyl)-columbianetin as a novel allergic rhinitis-control agent. Life Sci. 2014; 98(2):103-12. DOI: 10.1016/j.lfs.2014.01.003. View

Willart M, Deswarte K, Pouliot P, Braun H, Beyaert R, Lambrecht B . Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med. 2012; 209(8):1505-17. PMC: 3409497. DOI: 10.1084/jem.20112691. View

Wang Y, McCusker C . Interleukin-13-dependent bronchial hyper-responsiveness following isolated upper-airway allergen challenge in a murine model of allergic rhinitis and asthma. Clin Exp Allergy. 2005; 35(8):1104-11. DOI: 10.1111/j.1365-2222.2005.02301.x. View

Ciprandi G, Vizzaccaro A, Cirillo I, Tosca M, Massolo A, Passalacqua G . Nasal eosinophils display the best correlation with symptoms, pulmonary function and inflammation in allergic rhinitis. Int Arch Allergy Immunol. 2005; 136(3):266-72. DOI: 10.1159/000083953. View

10.

Iwasaki M, Saito K, Takemura M, Sekikawa K, Fujii H, Yamada Y . TNF-alpha contributes to the development of allergic rhinitis in mice. J Allergy Clin Immunol. 2003; 112(1):134-40. DOI: 10.1067/mai.2003.1554. View

11.

Jeffery C, Bhutani M, Vliagoftis H, Wright E, Seikaly H, Cote D . Association between allergic rhinitis and asthma in a Northern Alberta cohort. J Otolaryngol Head Neck Surg. 2013; 42:58. PMC: 3895780. DOI: 10.1186/1916-0216-42-58. View

12.

Bahekar P, Shah J, Ayer U, Mandhane S, Thennati R . Validation of guinea pig model of allergic rhinitis by oral and topical drugs. Int Immunopharmacol. 2008; 8(11):1540-51. DOI: 10.1016/j.intimp.2008.06.010. View

13.

Hauber H, Bergeron C, Toda M, Kontolemos M, Holroyd K, Levitt R . Up-Regulation of Interleukin-9 and the Interleukin-9-Associated Calcium-Activated Chloride Channel hCLCA1 in Nasal Mucosa Following In Vivo Allergen Challenge. Allergy Asthma Clin Immunol. 2010; 3(1):19-23. PMC: 2873628. DOI: 10.1186/1710-1492-3-1-19. View

14.

Thakare V, Osama M, Naik S . Therapeutic potential of curcumin in experimentally induced allergic rhinitis in guinea pigs. Int Immunopharmacol. 2013; 17(1):18-25. DOI: 10.1016/j.intimp.2013.04.025. View

15.

Mo J, Kang E, Quan S, Rhee C, Lee C, Kim D . Anti-tumor necrosis factor-alpha treatment reduces allergic responses in an allergic rhinitis mouse model. Allergy. 2011; 66(2):279-86. DOI: 10.1111/j.1398-9995.2010.02476.x. View

16.

Cai Y, Cao Y, Lu S, Xu C, Cardell L . Infliximab alleviates inflammation and ex vivo airway hyperreactivity in asthmatic E3 rats. Int Immunol. 2011; 23(7):443-51. DOI: 10.1093/intimm/dxr032. View

17.

Wei-Xu H, Qin X, Zhu W, Yuan-yi C, Li-feng Z, Zhi-yong L . Therapeutic potential of anti-IL-1β IgY in guinea pigs with allergic asthma induced by ovalbumin. Mol Immunol. 2013; 58(1):139-49. DOI: 10.1016/j.molimm.2013.11.006. View

18.

Guo-Zhu H, Xi-Ling Z, Zhu W, Li-Hua W, Dan H, Xiao-Mu W . Therapeutic potential of combined anti-IL-1β IgY and anti-TNF-α IgY in guinea pigs with allergic rhinitis induced by ovalbumin. Int Immunopharmacol. 2014; 25(1):155-61. DOI: 10.1016/j.intimp.2014.12.002. View

19.

Widegren H, Erjefalt J, Korsgren M, Andersson M, Greiff L . Effects of intranasal TNFalpha on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis. Respir Res. 2008; 9:15. PMC: 2253533. DOI: 10.1186/1465-9921-9-15. View

20.

Baraniuk J . Pathogenesis of allergic rhinitis. J Allergy Clin Immunol. 1997; 99(2):S763-72. DOI: 10.1016/s0091-6749(97)70125-8. View